TUYET NGUYEN: Open Payments
NPI 1396974671 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,881 in 51 payments from 15 companies in 2025. Trend: 2023 $1,619 · 2024 $1,738 · 2025 $1,881
Food & beverage: $1,881
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $387 |
| Intra-Sana Laboratories | 5 | $350 |
| Abbott Laboratories | 1 | $215 |
| Phathom Pharmaceuticals, Inc. | 6 | $208 |
| Dexcom, Inc. | 6 | $175 |
| Astellas Pharma US Inc | 2 | $152 |
| Exact Sciences Corporation | 6 | $96 |
| AstraZeneca Pharmaceuticals LP | 5 | $92 |
| Lilly USA, LLC | 4 | $66 |
| Amgen Inc. | 2 | $39 |
Products named: RELTONE 200 MG, FREESTYLE LIBRE 3, VOQUEZNA, Ozempic, Veozah, DEXCOM G7 GSS (161), AIRSUPRA, Cologuard Collection Kit.
Industry payments across NV — which companies pay providers there.
